Stocks and Investing Stocks and Investing
Mon, March 25, 2019
Fri, March 22, 2019
Thu, March 21, 2019

Steve Chesney Downgraded (BIIB) to Hold on, Mar 21st, 2019


Published on 2024-10-26 12:42:50 - WOPRAI, Steve Chesney
  Print publication without navigation


Steve Chesney of Atlantic Equities, Downgraded "Biogen Inc." (BIIB) to Hold on, Mar 21st, 2019.

Steve has made no other calls on BIIB in the last 4 months.



There are 4 other peers that have a rating on BIIB. Out of the 4 peers that are also analyzing BIIB, 3 agree with Steve's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Adnan Butt of "Guggenheim" Downgraded from Strong Buy to Hold and Decreased Target to $325 on, Friday, February 22nd, 2019
  • Ian Somaiya of "BMO Capital" Initiated at Hold and Held Target at $322 on, Friday, February 22nd, 2019
  • Thomas Shrader of "Stifel" Downgraded from Strong Buy to Hold and Decreased Target to $346 on, Thursday, February 21st, 2019


This is the rating of the analyst that currently disagrees with Steve


  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $401 on, Wednesday, December 19th, 2018

Contributing Sources